Outcome of "indefinite for dysplasia" in inflammatory bowel disease: Correlation with DNA flow cytometry and other risk factors of colorectal cancer

Human Pathology

Volumn 46, Issue 7, 2015, Pages 939-947

  Choi, Won Tak ^a   Rabinovitch, Peter S ^a   Wang, Dongliang ^b   Westerhoff, Maria ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Aneuploidy; Crohn's; Dysplasia; Flow cytometry; Indefinite; Ulcerative colitis

Indexed keywords

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER RISK; COHORT ANALYSIS; COLORECTAL CANCER; DNA CONTENT; DNA DETERMINATION; ELECTRONIC MEDICAL RECORD; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GASTROINTESTINAL DYSPLASIA; HUMAN; HUMAN TISSUE; INFLAMMATORY BOWEL DISEASE; INTESTINE BIOPSY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIMARY SCLEROSING CHOLANGITIS; BIOPSY; CANCER GRADING; CLINICAL TRIAL; COLITIS, ULCERATIVE; COLONOSCOPY; COLORECTAL NEOPLASMS; CROHN DISEASE; DISEASE COURSE; GENETICS; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE; RISK ASSESSMENT; RISK FACTOR; TIME; UNITED STATES; YOUNG ADULT;

DNA;

ADULT; AGED; ANEUPLOIDY; BIOPSY; COLITIS, ULCERATIVE; COLONOSCOPY; COLORECTAL NEOPLASMS; CROHN DISEASE; DISEASE PROGRESSION; DNA; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; WASHINGTON; YOUNG ADULT;

EID: 84931009727     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2015.03.009     Document Type: Article

References (23)

1. S.H. Itzkowitz, and N. Harpaz Diagnosis and management of dysplasia in patients with inflammatory bowel diseases Gastroenterology 126 2004 1634 1648
2. C.D. Gillen, H.A. Andrews, P. Prior, and R.N. Allan Crohn's disease and colorectal cancer Gut 35 1994 651 655
3. D.B. Sachar Cancer in Crohn's disease: dispelling the myths Gut 35 1994 1507 1508
4. H. Jayaram, J. Satsangi, and R.W. Chapman Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction? Gut 48 2001 430 434
5. M. Rutter, B. Saunders, and K. Wilkinson Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis Gastroenterology 126 2004 451 459
6. J. Eaden, K. Abrams, A. Ekbom, E. Jackson, and J. Mayberry Colorectal cancer prevention in ulcerative colitis: a case-control study Aliment Pharmacol Ther 14 2000 145 153
7. P. Karlén, D. Kornfeld, O. Broström, R. Löfberg, P.G. Persson, and A. Ekbom Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study Gut 42 1998 711 714
8. R.H. Riddell, H. Goldman, and D.F. Ransohoff Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications Hum Pathol 14 1983 931 968
9. R. Löfberg, T. Caspersson, B. Tribukait, and A. Ost Comparative DNA analyses in longstanding ulcerative colitis with aneuploidy Gut 30 1989 1731 1736
10. O. Broström, R. Löfberg, A. Ost, and H. Reichard Cancer surveillance of patients with longstanding ulcerative colitis: a clinical, endoscopical, and histological study Gut 27 1986 1408 1413
11. J. Eaden, K. Abrams, H. McKay, H. Denley, and J. Mayberry Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis J Pathol 194 2001 152 157
12. M.F. Dixon, L.J. Brown, and H.M. Gilmour Observer variation in the assessment of dysplasia in ulcerative colitis Histopathology 13 1988 385 397
13. T. Ullman, V. Croog, N. Harpaz, D. Sachar, and S. Itzkowitz Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis Gastroenterology 125 2003 1311 1319
14. W.R. Connell, J.E. Lennard-Jones, C.B. Williams, I.C. Talbot, A.B. Price, and K.H. Wilkinson Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis Gastroenterology 107 1994 934 944
15. J.A. Leighton, B. Shen, and T.H. Baron ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease Gastrointest Endosc 63 2006 558 565
16. F.A. Farraye, R.D. Odze, and J. Eaden AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease Gastroenterology 138 2010 738 745
17. G.V. Papatheodoridis, A. Zizi-Serbetzoglou, V. Xourgias, I. Elemenoglou, and D.G. Karamanolis Indefinite dysplasia in ulcerative colitis has little clinical significance and is not associated with p53 protein accumulation Am J Gastroenterol 93 1998 285 286
18. J.R. Pekow, J.T. Hetzel, and J.A. Rothe Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis Inflamm Bowel Dis 16 2010 1352 1356
19. C.E. Rubin, R.C. Haggitt, and G.C. Burmer DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis Gastroenterology 103 1992 1611 1620
20. T.V. Shankey, P.S. Rabinovitch, and B. Bagwell Guidelines for implementation of clinical DNA cytometry: International Society for Analytical Cytology Cytometry 14 1993 472 477
21. G.C. Burmer, P.S. Rabinovitch, and R.C. Haggitt Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele Gastroenterology 103 1992 1602 1610
22. R. Löfberg, B. Tribukait, A. Ost, O. Broström, and H. Reichard Flow cytometric DNA analysis in longstanding ulcerative colitis: a method of prediction of dysplasia and carcinoma development? Gut 28 1987 1100 1106
23. J. Rutegård, L. Ahsgren, R. Stenling, and G. Roos DNA content and mucosal dysplasia in ulcerative colitis. Flow cytometric analysis in patients with dysplastic or indefinite morphologic changes in the colorectal mucosa Dis Colon Rectum 32 1989 1055 1059